Australia TGA ARTG recordPeripheral venous endovascular stent-graft
Australia TGA ARTG Registered Device · Bard Australia Pty Ltd · Angiomed GmbH & Co Medizintechnik KG · Class I · Started October 08, 2019
Good Name: Bard Australia Pty Ltd - Peripheral venous endovascular stent-graft
- Risk Class
- Class I
- Product Type
- Single Device Product
- ARTG Category
- General-Export
- Start Date
- October 08, 2019
- Effective Date
- October 08, 2019
- Country
- Germany
- Address
- Wachhausstrasse 6, KARLSRUHE, 76227
The Covera™ Plus Vascular Covered Stent is indicated for the treatment of stenoses in the upper extremity venous outflow of patients dialyzing with an arterio-venous (AV) access graft or fistula and for the treatment of atherosclerotic lesions in iliac and femoral arteries with a reference vessel diameter of 4.5 mm to 9 mm.
Access comprehensive regulatory information for Peripheral venous endovascular stent-graft in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Bard Australia Pty Ltd, manufactured by Angiomed GmbH & Co Medizintechnik KG in Germany. The device registration started on October 08, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.